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Abstract
Background: The goal of  this study was to analyze the association between the FTO rs17817449 (G>T), G protein beta3 
subunit (GNB3) C825T and Melanocortin 4 receptor (MC4R) A822G single nucleotide polymorphism (SNP) with obesity in 
Saudi subjects.  
Methods: The subjects were divided into 2 groups according to BMI: Obese (BMI> 29.9) and non- obese control (BMI<24.9). 
Genotyping of  the target genes were determined by polymerase chain reaction (PCR) followed by restriction fragment length 
polymorphism analysis (RFLP). 
Results: We demonstrated the association of  the FTO genotype TT with increased weight, BMI and leptin levels in both males 
and females. However, there was no association of  genotype TT with fasting blood glucose, triglycerides and cholesterol levels. 
Regarding GNB3 rs5443 polymorphism, the likelihood of  obesity was linked to the TT genotype which was also associated with 
increased leptin levels.  On the other hand, the SNP of  MC4R A822G did not exhibit any significant association with obesity 
among studied subjects and showed only the presence of  homozygous AA genotype. 
Conclusion: The polymorphism of  FTO gene rs17817449 and GNB3 gene rs5443 (C825T) may be a genetic determinant of  
obesity in Saudi population whereas impact of  MC4R Asn274Ser change could not be detected.
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Introduction
Increasing prevalence of  obesity worldwide prompts 
many researchers to determine genetic factors underlying 
this disease. Dina et al.1 identified the link between the fat 
mass and obesity associated (FTO) genotype and obesi-
ty among obese European patients. Moreover, the FTO 
genotype has been reported to be associated with pheno-
typic variability of  BMI2. In parallel, the heterotrimeric G 
proteins, which are key components of  intracellular signal 
transduction and play a focal role in adipogenesis, have 
been proposed as candidate genes for obesity3. C825T 
polymorphism in the G protein beta3 subunit (GNB3) 
showed to play an important role in the determination of  
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obesity in the German population4.  In addition, Melano-
cortin 4 receptor (MC4R) deficiency that resulted from 
disruption of  one or both MC4R alleles represents the 
commonest monogenic form of  human obesity to date5. 
Of  note, frequency of  MC4R gene mutations was found 
to be lower in some studies than others, accounting for 
~ 6% of  severe obesity cases6-8. However a significance 
of  MC4R mutations in Asian obese populations has not 
been adequately detected compared with non-obese9-11.
    In Saudi Arabia, which has undergone significant eco-
nomic and cultural changes over the past thirty years, the 
prevalence of  obesity has increased dramatically especial-
ly among women and showed to be 23.6% versus 14.2% 
among men12. The significance of  FTO rs17817449, 
GNB3 rs5443 and MC4R gene mutation in Saudi obese 
populations has not been examined despite its associa-
tion with obesity in other parts of  the world. The aim 
of  this study was to evaluate the association of  the FTO 
rs17817449 (G>T), GNB3 rs5443 (C825T) and MC4R 
Asn274Ser (A822G) gene polymorphism with obesity 
and obesity-related metabolic traits in Saudi subjects.
 
Subjects and methods
Two hundred and twelve unrelated individuals were in-
cluded in this study, 107 males and 105 females, with 
mean age of  30.74+10.76 and 35.64+11.01 respective-
ly. The subjects were divided into 2 groups according to 
BMI; obese (BMI ≥ 30 kg/m2), included 51 males and 55 
females, and non - obese (BMI<24.9), included 56 males 
and 50 females. The subjects were recruited from No-
vember 2010 to Jun 2012 at King Fahd Medical Research 
Center (KFMRC), Mada’en Al-Fahad Medical Center 
and Medical administration in King Abdulaziz Universi-
ty. This study was approved by the ethics committee of  
the King Abdul-Aziz University Hospital, Jeddah, Saudi 
Arabia (reference No 741-12) for sample collection. Writ-
ten informed consent was obtained from all participants 
prior to the study.
After an overnight fast, blood samples were withdrawn in 
the morning from all subjects and divided into two parts. 
The first was transferred into EDTA containing tubes for 
DNA extraction and genotyping of  studied genes. The 
second part was transferred into a dry sterile tube and al-
lowed to clot. The serum was separated and divided into 
aliquots for biochemical and hormonal analysis. They 
were kept frozen at –80°C for further analysis.
Biochemical parameters such as fasting glucose, total 
cholesterol, triglyceride, and HDL-C were determined, by 
timed endpoint method, using commercially available test 
kits (Roche Diagnostics, Mannheim, Germany). LDL-C 
was calculated by the Friedewald formula.
Serum hormones were measured by ALPCO immu-
noassays kit (Human leptin Alpco, USA).
Genetic analyses and genomic DNA was extracted from 
whole blood in EDTA tubes using a standard salting-out. 
For FTO rs17817449, briefly, 5′-GGTGAAGAGGAG-
GAGATTGTGTAACTGG-3′ and 5′-GAAGCCCG-
TAGAAGTTTAGAGTAAATTGGG -3′ primers were 
used for amplification followed by restriction analysis 
with AlwNI enzyme (Fermentas, Lithuania) according 
to Hubacek et al.13. The uncut PCR product of  198 bp 
represents allele G, while restriction fragments of  99 bp 
represent allele T.
While for determination of  GNB3 C825T allele, 
5′-TGACCCACTTGCCACCCGTGC-3′ and -3′ -GCAG-
CAGCCAGGGCTGGC-5′ primers were used for ampli-
fication followed by cutting with BsaJ1 restriction enzyme 
(Biolabs, USA) according to Ohshiro et al.14, to determine 
the GNB3 C825T polymorphism. Alleles T represent the 
absence of  restriction site (268-bp) while alleles C indi-
cate the presence of  restriction site (152-bp and 116-bp 
bands).
The PCR thermal cycle include different temperature (94 
-95oC), denatures the double stranded DNA, 60 -72oC , 
annealing of   primer 72oC  DNA extension  polymerase.
 MC4R gene (A822G) polymorphism was detected by a 
PCR- restriction fragment length polymorphism accord-
ing to Yurtcu et al.15.
 
Statistical analysis: The p value at <0.05 was considered 
as significant. Deviation from Hardy–Weinberg equilibri-
um for FTO genotypes and GNB3 genotypes was calcu-
lated by the Chi-square  test.
Results
Analysis of  FTO rs17817449, GNB3 rs5443 (C825T) 
and MC4R A822G polymorphism are showed in figure 1. 
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In FTO polymorphism, the G allele generated an undi-
gested 198-bP product while the T allele yielded 99-bp 
fragment after digestion. While in GNB3 C825T poly-
morphism, alleles T represent the absence of  restriction 
site, giving a 268-bp PCR product, and alleles C indicate 
the presence of  restriction site giving 152-bp and 116-bp 
fragments. For MC4R gene (A822G) polymorphism, the 
uncut PCR product of  382 bp represents allele G, while 
restriction fragments of  45bp and 337bp represent allele 
A.
Figure 2, shows the genotype frequencies of  both FTO 
rs17817449 (G>T) and GNB3 rs5443 (C825T) polymor-
phism. In males, the genotyping of  FTO rs17817449 
(G>T) was as follows; homozygous GG (%25.5), het-
erozygous GT (43.1%), and homozygous TT (31.4%) in 
obese group versus GG (23.2%), GT (73.2 %) and TT 
(3.6 %) respectively in non-obese group. In females, the 
frequencies were GG (n= 10; 18.2%), GT (n= 29; 52.7%) 
and TT (29.1%) in obese group versus GG (16.0%), GT 
(80.0%) and TT (4.0%) respectively in non-obese group.
Genotype frequencies of  GNB3 rs5443 (C825T) poly-
morphism in males subjects were as follows; homozy-
gous CC (n=9; 17.6%), heterozygous CT (19.6%), and 
homozygous TT (n=32; 62.7%) in obese group versus 
CC (3.6 %), GT (75.0%) and TT (n=12; 21.4%) respec-
tively in non-obese group. In females the frequencies 
were CC(5.5%), CT (10.9%) and TT (83.6%) in obese 
group versus GG (10%), GT (70%) and TT (20%) re-
spectively in non-obese group.
Figure(1 a,b): Analysis of FTO rs17817449, GNB3 rs5443 and MC4R gene 
polymorphism
FTO rs17817449 (G>T) polymorphism (a) GNB3 rs5443 (C825T) polymorphism (b)
Figure(1 a,b): Analysis of FTO rs17817449, GNB3 rs5443 and MC4R gene 
polymorphism
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Figure (2 a,b): Genotypes and allele frequencies of FTO rs17817449 (G>T) 
and GNB3 rs5443 (C825T) among obese and non obese subjects
Genotypes and allele frequencies of GNB3 
rs5443 (C825T) among males (a)
Genotypes and allele frequencies of GNB3 
rs5443 (C825T) among females (b)
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Table 1: Anthropometric parameters and serum levels of biochemical 
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 The allele frequencies of  both FTO rs17817449 (G>T) 
and GNB3 rs5443 (C825T) are showed in table 2.
Comparative analysis of  the allelic frequencies of  FTO 
rs17817449 polymorphism in obese and non-obese 
groups revealed a significant difference in males (P=0.043) 
and non significant difference in females (P=0.097). The 
frequency of  the G allele was more pronounced among 
non obese, males and females, 59.8% and 56.0%, than 
obese subjects, 47.1% and 44.5% respectively. On the 
other hand, T allele was more pronounced among obese 
males and females, 52.9% and 55.5% than non-obese 
38.4% and 44.0% respectively.  The odd ratio between G 
allele and T allele in males and females was 1.75 and 1.58 
respectively. There was a statistically significant relation-
ship between T allele and obesity.
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Table 2: Allele frequencies of FTO rs17817449 
(G>T) and GNB3 rs5443 (C825T) Polymorphism among obese and non obese 
subjects (males and females). 
 
          a: G vs. T,  b: C vs. T,  P-value Person Chi-Square test  and c: CC vs. CC+CT, P-value Fisher Exact test. 
Sex and Allele 









FTO rs17817449 (G>T)   






(0.78-1.20)   
Male 







         
1.75 
(1.02-3.03) 
       
      1.35 
(1.00-1.82) 
  
T 38.4% (n=43) 
52.9% 
(n=54)   
Female 
G 56.0% (n=56) 
44.5% 
(n=49) 
0.097 1.58 (0.92-2.73) 
1.26 
(0.95-1.66) 
T 44.0% (n=44) 
55.5% 
(n=61) 
GNB3 rs5443 (C825T) 
CC+CT 78.6% (n=44) 
37.2% 
(n=19) 0.001
c 0.096       (0.02-0.49) 
0.26      (0.0
7-0.92) 
Male 
C 41.1% (n=46) 
27.5% 
(n=28) 
0.036b 1.84 (1.04-3.26) 
1.23 
(1.01-1.50) 




C 45% (n=45) 
10.91% 
(n=12) 
<0.0001b 6.68 (3.26-13.69) 
1.62 
(1.34-1.96) 
T 55% (n=55) 
89.09% 
(n=98) 
          
The association of  FTO rs17817449 (G>T) genotypes 
with obesity and metabolic related traits are showed in 
table 3. Both TT and GG genotypes had a higher weight 
and BMI values than that found in heterogeneous geno-
type GT. Also, the TT showed a higher weight and BMI 
values than that found in genotype GG, which was sig-
nificant among males and only significant regarding BMI 
among females. HDL-C levels were lower in genotype TT 
in comparison with those found in genotypes GG and 
GT. This difference was only significant among male sub-
jects between TT and GG genotypes.
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Regarding the hormones, both TT and GG genotypes 
showed to have significant higher leptin levels than that 
found in GT genotypes among females; while in males, 
this difference was only significant between TT and GT 
genotypes. A similar association was found with C pep-
tide, where genotypes TT and GG had higher C peptide 
levels compared to that found in GT genotype among 
males or females, with only statistical difference between 
GG and GT among females.
Table 3: FTO genotype frequencies, anthropometric, biochemical and 
hormonal parameters in male and female subjects 
  
  
        Results are expressed as mean± SD, and were compared by t-test (P < 0.05). 
       P-valuea: GG vs. GT 
      P-valueb : GG vs. TT 
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On the other hand, the growth hormone (GH) levels 
were lower in genotypes TT and GG than in genotype 
GT. This difference was only significant between TT and 
GT genotypes among males. The c-peptide is a good in-
dex for insulin secretion and clinically related to metabol-
ic syndrome and diabetes.
In table (4) the genotype TT and CC were associated 
with higher significant weight and BMI than that found 
in genotype CT among males, while among females 
the difference was only significant between TT and CT 
genotypes.   Regarding the hormones, the TT genotype 
showed  higher leptin levels than that found in CT or CC 
genotype among males and females. This difference was 
only significant between TT and CT genotypes. A similar 
association was found with C peptide, where genotype 
TT showed higher C peptide levels than that found in CT 
and CC genotypes. To the contrary, the growth hormone 
(GH) levels were significantly lower in genotype TT com-
pared with that of  genotype CT in males and females but 
not statistically different from that found in CC genotype.
Table 4: G-protein β3 subunit gene frequencies, anthropometric, biochemical and hormonal 
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Discussion
The present study showed that serum leptin level increas-
es significantly as the BMI increases (table 1). Similar re-
sults have been reported by previous studies where leptin 
concentrations showed to be correlated in healthy indi-
viduals with the body fat content and body mass index18 
Several factors have been proposed for such increase of  
leptin levels like; a diminished response in the leptin re-
ceptor signalling pathway, poor penetration of  the blood-
brain barrier by leptin, the presence of  less active molec-
ular forms of  leptin or Leptin resistance19.  
It has long been known that C-peptide levels in the blood 
and urine provide an accurate estimate of  insulin se-
cretion rates. The association between C-peptide levels 
with diabetes severity and obesity has been hypothesized 
in previous studies20-23. In the current study, the fasting 
C-peptide levels were found to be significantly higher in 
obese group in comparison with that found in non-obese 
group (table 1). Our study results and those by others, 
Pasquali et al.24, Park et al.25, suggested that obese subjects 
are hyperinsulinemic.
In the current study, we explored the association of  FTO 
rs17817449 (G>T), GNB3 rs5443 (C825T) and MCR4 
(A822G) genes SNP with obesity and obesity-related 
metabolic traits in a small sample of  Saudi population. 
The FTO gene is highly polymorphic, and several poly-
morphisms of  the gene have been found to be associat-
ed with obesity or obesity phenotypes26-30. Among such 
polymorphisms, the FTO rs17817449 gene SNP showed 
to be associated with obesity in several populations30-32. In 
the present study, the association of  FTO genotype TT 
with higher BMI was stronger than that of  genotype GG. 
Although this seems contradictory to several earlier re-
ports, it is still possible and can be explained by the much 
lower frequency of  FTO rs17817449 in Asian and Afri-
can populations than those in white populations, showing 
a smaller effect than that detected in Europeans31.
In parallel, fried food consumption and particularly satu-
rated fatty acids, seemed to determine or modulate the as-
sociation between the FTO risk-allele and higher BMI30. 
Obviously, the role of  genetic variation at the FTO locus 
in predisposing to obesity in Asian, Saudi, populations 
warrants further investigation especially in relation to the 
epidemiological transition and access to a calorie-rich 
diet.
In the current study, we did not find any association be-
tween FTO rs17817449 SNP and fasting glucose. This 
is in line with the findings of  Hubacek et al.19 FTO was 
first identified as a type 2 diabetes susceptibility gene, but, 
as further adjustment for BMI abolished the association 
with diabetes32, it was suggested that FTO is primarily an 
obesity-susceptibility locus.
 
In this study, we showed that the FTO rs17817449 was 
associated with higher leptin concentrations regardless of  
gender. In parallel, the association of  the FTO rs9939609 
polymorphism with serum leptin concentrations showed 
association between the A allele and serum leptin levels, 
but it was not adjusted for BMI and was considered as a 
result of  increased adiposity28.
 In the present study, the TT genotype was associated 
with a decrease of  GH in comparison with GT geno-
type. This association was found among males when 
stratified for gender. The association of  GH deficiency 
with obesity in humans and determining whether or not 
FTO regulates GH and/ or other hormones secreted by 
the hypothalamus-pituitary axis will greatly elucidate the 
FTO’s physiological function in future22. Regarding FTO 
genotype and C-peptide, the association was statistically 
significant between GG and GT genotypes in the total 
group and female gender. It was reported that,  there was 
no significant association between the FTO rs17817449 
SNP and C-peptide in male gender.
In this study, the GNB3 TT genotype was more frequent 
in obese subjects, males or females, the frequency was 
(62.7% and 83.6%) versus (21.4% and 20%) respective-
ly, in non-obese subjects suggesting the possible relation 
with obesity. In parallel, we demonstrated a significant as-
sociation of  the TT genotype with higher levels of  weight 
and BMI compared with CT genotype. The T allele of  
GNB3 rs5443 SNP has been reported to predispose to 
obesity in German, Chinese and South African popula-
tions.
 In the current study, we investigated Asn274Ser non-
synonymous mutation of  the MC4R gene that has been 
linked to obesity in previous studies21. We only detect-
ed the presence of  homozygous AA genotype while AG 
and GG were not observed and MC4R gene SNP did 
not exhibit any significant association with obesity among 
studied subjects. However, a positive association between 
Asn274Ser mutation and obesity in Turkish population.   
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Conclusion
The polymorphism of  FTO gene rs17817449 and GNB3 
gene rs5443 (C825T) may be a genetic determinant of  
obesity in Saudi population, whereas impact of  MC4R 
Asn274Ser change could not be detected in our sample.
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